当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析

金城医药

(300233)

  

流通市值:63.30亿  总市值:65.37亿
流通股本:3.72亿   总股本:3.84亿

金城医药(300233)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.36亿元,每股收益0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益381342.77万元,未分配利润88299.80万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产547138.42万元,负债165795.65万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入721,919,205.163,373,387,400.672,515,318,391.161,758,578,253.52
营业总成本682,091,200.853,103,164,108.882,333,206,417.211,604,450,464.21
营业利润50,092,786.77267,138,172.88195,266,352.27162,771,273.34
利润总额49,799,982.84268,448,023.16196,941,619.51163,999,839.88
净利润36,298,903.66207,735,344.13162,100,822.21138,962,484.83
其他综合收益-23,268,580.25--
综合收益总额36,298,903.66231,003,924.38162,100,822.21138,962,484.83
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,184,257,009.162,258,285,131.732,211,713,748.212,303,004,174.63
非流动资产合计3,287,127,224.513,346,705,609.983,392,226,128.673,434,801,957.19
资产总计5,471,384,233.675,604,990,741.715,603,939,876.885,737,806,131.82
流动负债合计1,122,888,801.631,230,974,936.041,339,988,545.731,428,847,510.69
非流动负债合计535,067,733.94541,861,651.66501,926,879.36513,464,407.93
负债合计1,657,956,535.571,772,836,587.71,841,915,425.091,942,311,918.62
归属于母公司股东权益合计3,747,011,365.753,766,981,964.993,699,709,849.543,716,657,502.28
股东权益合计3,813,427,698.13,832,154,154.013,762,024,451.793,795,494,213.2
负债和股东权益合计5,471,384,233.675,604,990,741.715,603,939,876.885,737,806,131.82
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计598,515,054.412,983,715,110.852,316,827,573.741,664,940,444.24
经营活动现金流出小计607,080,446.362,687,129,386.682,115,388,750.921,489,989,131.7
经营活动产生的现金流量净额-8,565,391.95296,585,724.17201,438,822.82174,951,312.54
投资活动现金流入小计288,038,948.22412,443,966.46249,565,290.53166,781,815.19
投资活动现金流出小计297,561,108.78496,759,683.16356,475,243.27190,517,775.45
投资活动产生的现金流量净额-9,522,160.56-84,315,716.7-106,909,952.74-23,735,960.26
筹资活动现金流入小计108,000,000245,490,000193,540,000192,540,000
筹资活动现金流出小计173,461,298.33489,260,905.66349,159,037.29282,356,089.74
筹资活动产生的现金流量净额-65,461,298.33-243,770,905.66-155,619,037.29-89,816,089.74
汇率变动对现金及现金等价物的影响1,463,5855,963,880.284,242,300.793,885,201.35
现金及现金等价物净增加额-82,085,265.84-25,537,017.91-56,847,866.4265,284,463.89
期末现金及现金等价物余额796,398,844.56878,484,110.4847,173,261.89969,305,592.2
TOP↑